LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

Recruiting

Phase: PHASE3 Conditions: NASH With Fibrosis, MASH With Fibrosis

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT ID: NCT06465186

This clinical trial is studying a new medicine called efinopegdutide to see if it can help people with a liver disease known as metabolic dysfunction-associated steatohepatitis (MASH), which is cau...

Recruiting

Phase: PHASE2 Conditions: NAFLD, Non-alcoholic Fatty Liver Disease +3 more

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Recruiting

Conditions: Lumbar Spinal Stenosis

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

NCT ID: NCT06245408

This clinical trial is studying a new treatment called dazodalibep for patients with Sjögren's Syndrome (SS), specifically those who experience moderate to severe symptoms. The main goal is to see ...

Recruiting

Phase: PHASE3 Conditions: Sjögren's Syndrome (SS)

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT ID: NCT07104383

This clinical trial is studying a new medicine called VK2735 to see if it can help adults who have Type 2 Diabetes and are overweight or obese lose weight. The study will last about 78 weeks (about...

Recruiting

Phase: PHASE3 Conditions: Weight Loss

VK2735 for Weight Management Phase 3

NCT ID: NCT07104500

This clinical trial is studying a new medication called VK2735 to see if it can help adults who are overweight or obese lose weight safely and effectively. The study will last about 78 weeks and wi...

Recruiting

Phase: PHASE3 Conditions: Weight Loss

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

NCT ID: NCT06641076

This clinical trial is studying a medication called sonelokimab to see how well it works and how safe it is for adults with active psoriatic arthritis, a type of arthritis that can cause joint pain...

Recruiting

Phase: PHASE3 Conditions: Arthritis, Psoriatic

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

NCT ID: NCT06641089

This clinical trial is studying a new treatment called sonelokimab for adults with active psoriatic arthritis (PsA) who haven’t had enough relief from their previous treatments using anti-TNFα medi...

Recruiting

Phase: PHASE3 Conditions: Arthritis, Psoriatic

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

NCT ID: NCT06972056

The APT Comparison Study is a clinical trial designed to compare the effectiveness of three medications used to prevent migraines: atogepant (a newer option), topiramate, and propranolol (two older...

Recruiting

Phase: PHASE4 Conditions: Migraine

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

NCT ID: NCT06632457

The LIVERAGE™ study is researching whether a medication called survodutide can help adults with a liver disease known as non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction Associated Steatohepatitis

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

NCT ID: NCT05519475

This clinical trial is exploring a new investigational drug called ALN-HSD to treat a liver condition known as non-alcoholic steatohepatitis (NASH), which is a serious form of fatty liver disease. ...

Recruiting

Phase: PHASE2 Conditions: Metabolic Dysfunction-associated Steatohepatitis (MASH)

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

NCT ID: NCT06411249

This clinical trial is studying the effectiveness and safety of a medication called belimumab in adults who have been diagnosed with early systemic lupus erythematosus (SLE) and are still experienc...

Recruiting

Phase: PHASE4 Conditions: Systemic Lupus Erythematosus

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT ID: NCT06528314

This clinical trial is studying a new medication called efruxifermin (EFX) for people with compensated cirrhosis caused by nonalcoholic steatohepatitis (NASH) or metabolic dysfunction-associated st...

Recruiting

Phase: PHASE3 Conditions: NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

NCT ID: NCT06868264

The C-BEYOND clinical trial is studying two different treatment options for adults with chronic Hepatitis C virus (HCV) infection: BEM/RZR and SOF/VEL. The main goal is to find out which treatment ...

Recruiting

Phase: PHASE3 Conditions: HEPATITIS C VIRUS CHRONIC INFECTION

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

NCT ID: NCT06864026

The TOGETHER AMPLIFY-PsA clinical trial is studying how effective the medication tirzepatide is when added to ixekizumab treatment for people with active psoriatic arthritis (PsA) who are also over...

Recruiting

Phase: PHASE4 Conditions: Psoriatic Arthritis, Overweight or Obesity

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT ID: NCT06318169

The ENLIGHTEN-Fibrosis trial is studying a new treatment called pegozafermin for adults with a liver condition known as Metabolic Dysfunction-associated Steatotic Liver Disease (MASH), which can al...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

NCT ID: NCT06859294

This clinical trial is studying a new medication called LY3541860 to see how it helps adults with moderately to severely active rheumatoid arthritis (RA) who have not responded well to at least one...

Recruiting

Phase: PHASE2 Conditions: Rheumatoid Arthritis

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT ID: NCT06419374

This clinical trial is studying a medication called pegozafermin to see how well it works and how safe it is for people with compensated cirrhosis caused by a liver condition known as Metabolic Dys...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Main Menu

Clinical Trials in Flagstaff, Arizona

32 Active Trials Found in Flagstaff

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

VK2735 for Weight Management Phase 3

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH